IP Library Granted Patent US 12,544,530
Granted Patent B2
US 12,544,530 · App. 18/665,685 · Granted Feb 10, 2026

Vent and vent adaptor for patient interface

Inventors: Muditha Pradeep Dantanarayana (Sydney, AU); Charles Harry Finch (Sydney, AU); Justin John Formica (Sydney, AU); Richard Llewelyn Jones (Sydney, AU); Joseph Samuel Ormrod (Sydney, AU); Jamie Graeme Wehbeh (Sydney, AU); Chia Ik Tan (Sydney, AU)
Assignee: ResMed Pty Ltd
A61M16/208A61M16/0816A61M39/24F16K15/145A61M16/06A61M16/0666A61M16/0683A61M16/0875A61M2202/0225
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,530
App. No.
18/665,685
Granted
Feb 10, 2026
Kind
B2
Abstract

A vent system for use during respiratory therapy with a flow of pressurized gas may provide a continuous vent flow of gas. The vent system may include a vent housing having an outer wall; an inner wall, the inner wall defining an inlet for the flow of gas; and a base positioned between the outer wall and the inner wall, the base having at least one first orifice and at least one second orifice. The vent system may include a membrane, the membrane being shaped and dimensioned such that the membrane does not cover the at least one first orifice to allow the vent flow through the at least one first orifice, and the membrane being shaped and dimensioned such that in a first position the membrane is positioned over the at least one second orifice to allow the vent flow through the at least one second orifice.

Claims (31)

1 . A vent system for use with a patient interface during respiratory therapy of a patient with a therapy flow of gas pressurized above ambient pressure, the vent system providing a vent flow of gas to discharge gas exhaled by the patient from a pressurized volume, the vent flow being continuous during the respiratory therapy, the vent system comprising:

a vent housing comprising a base having a plurality of first orifices and a plurality of second orifices extending through the base to allow gas to be discharged to atmosphere from the pressurized volume, and the plurality of second orifices being positioned radially outward of the plurality of first orifices with respect to a central axis through the base; and

a membrane positioned adjacent to the base within the pressurized volume,

wherein the pressurized volume is in fluid communication with atmosphere through the plurality of second orifices throughout a therapeutic pressure range,

wherein the membrane is configured such that an increase in pressure within the pressurized volume causes the membrane to restrict a first vent flow through the plurality of first orifices throughout the therapeutic pressure range, and

wherein restriction of the first vent flow through the plurality of first orifices causes an increase in a second vent flow through the plurality of second orifices such that the vent flow through the plurality of first orifices and the plurality of second orifices is approximately constant throughout the therapeutic pressure range,

wherein the vent housing comprises an outer wall and an inner wall, the inner wall defining an inlet for the therapy flow of gas, and

wherein the base is positioned between the outer wall and the inner wall.

2 . The vent system of claim 1 , wherein the vent flow is greater than or equal to the sum of the first vent flow and the second vent flow.

3 . The vent system of claim 1 , wherein the membrane is elastically deformable toward the base in use such that the first vent flow is restricted as the membrane is deflected towards the base.

4 . The vent system of claim 3 , wherein the membrane is configured to deflect closer to the base as the therapy pressure increases above a threshold therapy pressure value.

5 . The vent system of claim 4 , wherein the membrane is configured to decrease the first vent flow such that the second vent flow increases as the membrane is deflected closer to the base due to increasing the therapy pressure above the threshold therapy pressure value.

6 . The vent system of claim 1 , wherein the base further comprises an inner base and an outer base.

7 . The vent system of claim 6 , further comprising a plurality of membrane spacers extending from the inner base.

8 . The vent system of claim 7 , wherein the membrane is supported over the plurality of first orifices on the membrane spacers such that increasing the therapy pressure above a threshold therapy pressure value causes the membrane to deflect towards the inner base.

9 . The vent system of claim 8 , wherein the membrane is configured such that a membrane-inner base gap defined between the membrane and the inner base decreases as the therapy pressure is increased above the threshold therapy pressure value.

10 . The vent system of claim 9 , wherein the membrane is configured such that as the membrane-inner base gap decreases the first vent flow decreases and the second vent flow increases.

11 . The vent system of claim 6 , wherein the outer wall, the inner wall, the inner base, the outer base, and the membrane are circular.

12 . The vent system of claim 11 , wherein the outer wall, the inner wall, the inner base, the outer base, and the membrane are concentric.

13 . The vent system of claim 1 , wherein the membrane comprises an elastically deformable material.

14 . The vent system of claim 13 , wherein the elastically deformable material is silicone.

15 . The vent system of claim 1 , wherein the vent housing is formed from a single, homogeneous piece of a relatively rigid material.

16 . The vent system of claim 15 , wherein the relatively rigid material is polycarbonate.

17 . The vent system of claim 1 , wherein the membrane is not attached to the vent housing such that the membrane is freely movable towards and away from the base.

18 . The vent system of claim 1 , wherein the membrane is shaped and dimensioned such that the membrane does not cover the plurality of second orifices in any position.

19 . A patient interface comprising:

a seal-forming structure;

a plenum chamber joined to the seal-forming structure;

a positioning and stabilising structure to secure the patient interface on the patient in use; and

the vent system of claim 1 .

20 . The patient interface of claim 19 , further comprising a vent connector tube or a decoupling structure to fluidly connect the vent system to the plenum chamber.

Assignments (4)
CHANGE OF NAME Recorded Jul 10, 2024
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 068262/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2024
From: DANTANARAYANA, MUDITHA PRADEEP; FINCH, CHARLES
To: RESMED LIMITED
Reel/Frame 067431/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2024
From: FORMICA, JUSTIN JOHN; ORMROD, JOSEPH SAMUEL; TAN, CHIA IK; WEHBEH, JAMIE GRAEME
To: RESMED LIMITED
Reel/Frame 067431/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2024
From: JONES, RICHARD LLEWELYN
To: RESMED LIMITED
Reel/Frame 067431/0958 →
Priority Claims (1)
WO PCT/AU2016/050893 · Sep 23, 2016 · international
Continuity (5)
Continuation 17852563 · Jun 29, 2022
Continuation 16334442
Provisional Application 62443305 · Jan 6, 2017
Provisional Application 62397544 · Sep 21, 2016
Related Publication 20240299697A1 · Sep 12, 2024
References Cited (187)
US 2944547A · Ziherl et al. · 1960 [cited by applicant]
US 3109425A · Gongoll · 1963 [cited by applicant]
US 3630197A · Hirano · 1971 [cited by applicant]
US 3688794A · Forrest · 1972 [cited by applicant]
US 3883030A · Mathews · 1975 [cited by examiner]
US 3942547A · Pfitzner · 1976 [cited by applicant]
US 3995625A · Needham · 1976 [cited by applicant]
US 4007758A · Gray · 1977 [cited by applicant]
US 4354520A · Easley · 1982 [cited by applicant]
US 4406302A · Olesen · 1983 [cited by applicant]
US 4458679A · Ward · 1984 [cited by applicant]
US RE32553E · Bennett · 1987 [cited by applicant]
US 4782832A · Trimble et al. · 1988 [cited by applicant]
US 4821713A · Bauman · 1989 [cited by examiner]
US 4944310A · Sullivan · 1990 [cited by applicant]
US 4997217A · Kunze · 1991 [cited by applicant]
US 5002050A · McGinnis · 1991 [cited by applicant]
US 5005568A · Loescher · 1991 [cited by examiner]
US 5127400A · Devries · 1992 [cited by applicant]
US 5271601A · Bonzer et al. · 1993 [cited by applicant]
US 5465712A · Malis · 1995 [cited by examiner]
US 5645047A · Akers · 1997 [cited by examiner]
US 5647355A · Starr · 1997 [cited by applicant]
US 5685296A · Zdrojkowski et al. · 1997 [cited by applicant]
US 5687715A · Landis · 1997 [cited by applicant]
US 5738087A · King · 1998 [cited by applicant]
US 5762382A · Pernetti et al. · 1998 [cited by applicant]
US 5896857A · Hely et al. · 1999 [cited by applicant]
US 5937851A · Serowski et al. · 1999 [cited by applicant]
US 5979444A · Sherrod · 1999 [cited by applicant]
US 6189532B1 · Hely et al. · 2001 [cited by applicant]
US 6427692B1 · Höglund · 2002 [cited by applicant]
US 6460539B1 · Japuntich et al. · 2002 [cited by applicant]
US 6532959B1 · Berthon-Jones · 2003 [cited by applicant]
US 6561190B1 · Kwok · 2003 [cited by applicant]
US 6561191B1 · Kwok · 2003 [cited by applicant]
US 6581594B1 · Drew · 2003 [cited by applicant]
US 6584977B1 · Serowski · 2003 [cited by examiner]
US 6659102B1 · Sico · 2003 [cited by examiner]
US 6662803B2 · Gradon et al. · 2003 [cited by applicant]
US 7089939B2 · Waker et al. · 2006 [cited by applicant]
US 7096864B1 · Mayer et al. · 2006 [cited by applicant]
US 7134434B2 · Truitt et al. · 2006 [cited by applicant]
US 7207335B2 · Kwok · 2007 [cited by examiner]
US 7302950B2 · Berthon-Jones et al. · 2007 [cited by applicant]
US 7559326B2 · Smith et al. · 2009 [cited by applicant]
US 7726314B1 · Ming · 2010 [cited by applicant]
US 7866944B2 · Kenyon et al. · 2011 [cited by applicant]
US 7987847B2 · Wickham · 2011 [cited by applicant]
US 7987851B2 · Blom · 2011 [cited by applicant]
US 7997275B2 · Quinn · 2011 [cited by examiner]
US 8136524B2 · Ging · 2012 [cited by applicant]
US 8365731B2 · Ho et al. · 2013 [cited by applicant]
US 8439035B2 · Dantanarayana et al. · 2013 [cited by applicant]
US 8496004B2 · Lang et al. · 2013 [cited by applicant]
US 8544465B2 · Smith et al. · 2013 [cited by applicant]
US 8573201B2 · Rummery · 2013 [cited by applicant]
US 8573208B2 · Ho · 2013 [cited by applicant]
US 8636479B2 · Kenyon et al. · 2014 [cited by applicant]
US 8638014B2 · Sears et al. · 2014 [cited by applicant]
US 8733349B2 · Bath et al. · 2014 [cited by applicant]
US 9808594B2 · Dantanarayana et al. · 2017 [cited by applicant]
US 9861774B2 · Fu et al. · 2018 [cited by applicant]
US 10004924B1 · Anderson · 2018 [cited by applicant]
US 10086166B1 · Nashed · 2018 [cited by applicant]
US 10220179B2 · Dantanarayana et al. · 2019 [cited by applicant]
US 10864341B2 · Burz · 2020 [cited by applicant]
US 10898662B2 · Hoddart · 2021 [cited by applicant]
US 11420008B2 · Dantanarayana et al. · 2022 [cited by applicant]
US 20030037788A1 · Gallem · 2003 [cited by applicant]
US 20030079751A1 · Kwok · 2003 [cited by applicant]
US 20030154978A1 · Gradon et al. · 2003 [cited by applicant]
US 20030196656A1 · Moore · 2003 [cited by applicant]
US 20040094157A1 · Dantanarayana · 2004 [cited by examiner]
US 20040182396A1 · Dennis · 2004 [cited by applicant]
US 20040255948A1 · Smith · 2004 [cited by examiner]
US 20060174887A1 · Chandran · 2006 [cited by applicant]
US 20070083677A1 · Cecka et al. · 2007 [cited by applicant]
US 20080142013A1 · Hallett · 2008 [cited by examiner]
US 20080276937A1 · Davidson · 2008 [cited by applicant]
US 20090032026A1 · Price · 2009 [cited by applicant]
US 20090044808A1 · Guney et al. · 2009 [cited by applicant]
US 20090050156A1 · Ng et al. · 2009 [cited by applicant]
US 20090120434A1 · Smith et al. · 2009 [cited by applicant]
US 20090133694A1 · Solci et al. · 2009 [cited by applicant]
US 20090260628A1 · Flynn · 2009 [cited by applicant]
US 20100000534A1 · Kooij et al. · 2010 [cited by applicant]
US 20100083969A1 · Crumblin et al. · 2010 [cited by applicant]
US 20100282262A1 · Boussignac · 2010 [cited by applicant]
US 20110067709A1 · Doshi et al. · 2011 [cited by applicant]
US 20110120473A1 · Piper · 2011 [cited by examiner]
US 20110265796A1 · Amarasinghe · 2011 [cited by applicant]
US 20120055475A1 · Wilkinson · 2012 [cited by applicant]
US 20120325205A1 · Allum · 2012 [cited by examiner]
US 20120325206A1 · Allum · 2012 [cited by applicant]
US 20120325218A1 · Brambilla et al. · 2012 [cited by applicant]
US 20130104883A1 · Lalonde · 2013 [cited by applicant]
US 20130184602A1 · Brambilla · 2013 [cited by applicant]
US 20130213400A1 · Barlow · 2013 [cited by applicant]
US 20140261427A1 · Foote · 2014 [cited by examiner]
US 20140283837A1 · Turrisi · 2014 [cited by applicant]
US 20150114504A1 · Cecka · 2015 [cited by examiner]
US 20160051791A1 · Ewers · 2016 [cited by applicant]
US 20160158475A1 · Harrison · 2016 [cited by applicant]
US 20160310688A1 · Rothermel · 2016 [cited by applicant]
US 20160325067A1 · Harwood · 2016 [cited by applicant]
US 20160361575A1 · Gerson · 2016 [cited by applicant]
US 20170120084A1 · Tang · 2017 [cited by examiner]
US 20170239437A1 · Scheirlinck · 2017 [cited by applicant]
US 20180049638A1 · Ewers · 2018 [cited by applicant]
US 20180200467A1 · Finch · 2018 [cited by applicant]
US 20180207389A1 · Fyfe · 2018 [cited by applicant]
US 20180344953A1 · Cegla · 2018 [cited by applicant]
US 20190001095A1 · Rose · 2019 [cited by applicant]
US 20190105458A1 · Hammes · 2019 [cited by applicant]
US 20190209804A1 · Dantanarayana · 2019 [cited by applicant]
US 20220323712A1 · Dantanarayana et al. · 2022 [cited by applicant]
CA 2368825A1 · 2003 [cited by applicant]
CN 1462198A · 2003 [cited by applicant]
CN 101098727A · 2008 [cited by applicant]
CN 101495170A · 2009 [cited by applicant]
CN 101516300A · 2009 [cited by applicant]
CN 202951092U · 2013 [cited by applicant]
CN 103974735A · 2014 [cited by applicant]
CN 105120935A · 2015 [cited by applicant]
CN 105636632A · 2016 [cited by applicant]
CN 108136150A · 2018 [cited by applicant]
EP 1027905A2 · 2000 [cited by applicant]
EP 3352830B1 · 2021 [cited by applicant]
GB 2500061A1 · 2013 [cited by applicant]
JP 2001506883A · 2001 [cited by applicant]
JP 2004522487 · 2004 [cited by applicant]
JP 2008540056 · 2008 [cited by applicant]
JP 2013501541A · 2013 [cited by applicant]
WO 98004310A1 · 1998 [cited by applicant]
WO 9826830A1 · 1998 [cited by applicant]
WO 98034665A1 · 1998 [cited by applicant]
WO 2000078381A1 · 2000 [cited by applicant]
WO 0132250A1 · 2001 [cited by applicant]
WO 02051486A1 · 2002 [cited by applicant]
WO 2002051486A1 · 2002 [cited by applicant]
WO 2004073778A1 · 2004 [cited by applicant]
WO 2005063326A1 · 2005 [cited by applicant]
WO 2005063328A1 · 2005 [cited by applicant]
WO 2006074513A1 · 2006 [cited by applicant]
WO 2006130903A1 · 2006 [cited by applicant]
WO 2009052560A1 · 2009 [cited by applicant]
WO 2009127049A1 · 2009 [cited by applicant]
WO 2010135785A1 · 2010 [cited by applicant]
WO 2011080604A1 · 2011 [cited by applicant]
WO 2012171072A1 · 2012 [cited by applicant]
WO 2013020167A1 · 2013 [cited by applicant]
WO 2013040198A2 · 2013 [cited by applicant]
WO 2014097068A1 · 2014 [cited by applicant]
WO 2014129913A1 · 2014 [cited by applicant]
WO 2014205513A1 · 2014 [cited by applicant]
WO 2015013761A1 · 2015 [cited by applicant]
WO 2015041545A1 · 2015 [cited by applicant]
WO 2015052681A1 · 2015 [cited by applicant]
WO 2015073824A1 · 2015 [cited by applicant]
WO 2016041019A1 · 2016 [cited by applicant]
WO 2016141430A1 · 2016 [cited by applicant]
WO 2017014647A1 · 2017 [cited by applicant]
WO 2017021836A1 · 2017 [cited by applicant]
WO 2017049358A1 · 2017 [cited by applicant]
WO 2018052673A1 · 2018 [cited by applicant]
WO 2018053589A1 · 2018 [cited by applicant]
WO 2018126295A1 · 2018 [cited by applicant]
Examination Report dated Sep. 26, 2024 issued in New Zealand Application No. 792424 (3 pages). [cited by applicant]
Examination Report dated Sep. 26, 2024 issued in New Zealand Application No. 792426 (3 pages). [cited by applicant]
Examination Report dated Sep. 26, 2024 issued in New Zealand Application No. 792427 (3 pages). [cited by applicant]
Examination Report dated Nov. 18, 2024 issued in New Zealand Application No. 792427 (3 pages). [cited by applicant]
Examination Report dated Oct. 2, 2024 issued in New Zealand Application No. 751732 (3 pages). [cited by applicant]
Office Action dated Oct. 24, 2023 issued in Chinese Application No. 202111367716.1 with English translation (12 pages). [cited by applicant]
Notification of Grant dated Nov. 21, 2023 issued in Chinese Application No. 202111367716.1 (4 pages). [cited by applicant]
Extended European Search Report dated Oct. 21, 2022 issued in European Application No. 22171232.6 (8 pages). [cited by applicant]
First Examination Report dated Mar. 23, 2022 issued in Australian Application No. 2017329112 (3 pages). [cited by applicant]
Notice of Allowance dated Apr. 4, 2022 issued in Japanese Application No. 2019-515587 (3 pages). [cited by applicant]
Extended European Search Report dated Aug. 14, 2019 issued in European Application No. 17851991.4 (9 pages). [cited by applicant]
Office Action dated Aug. 30, 2021 issued in Japanese Application No. 2019-515587 with English translation (11 pages). [cited by applicant]
Office Action dated Dec. 31, 2020 issued in Chinese Application No. 201780067393.X with English translation (15 pages). [cited by applicant]
Office Action dated Dec. 21, 2020 issued in Japanese Application No. 2019-515587 with English translation (13 pages). [cited by applicant]
International Preliminary Report on Patentability issued in related International Application No. PCT/AU2017/051028 (6 pages). [cited by applicant]
[cited by applicant]
International Search Report for PCT/AU2017/051028, mailed Dec. 19, 2017, 5 Pages. [cited by applicant]
Written Opinion of the ISA for PCT/AU2017/051028, mailed Dec. 19, 2017, 5 Pages. [cited by applicant]
Extended European Search Report dated Jun. 11, 2025 issued in European Application No. 24223531.5 (8 pages). [cited by applicant]